All Genoss products are manufactured in accordance with a systematic
and rigorous quality control system based on ISO standards.
GENOSS DCB(n=39) | Company A(n=39) | P value | |
Diameter Stenosis in-segment,% | 23.5±10.9 | 30.4±11.2 | 0.020 |
Diameter Stenosis in-stent,% | 23.5±10.9 | 30.2±10.8 | 0.022 |
Late lumen loss in-segment,mm | 0.20±0.50 | 0.31±0.42 | 0.353 |
Late lumen loss in-stent,mm | 0.20±0.50 | 0.33±0.38 | 0.241 |
Binary restenosis in-segment,% | 0 | 6.5 (2) | 0.164 |
Binary restenosis in-stent,% | 0 | 3.2 (1) | 0.329 |
GENOSS DCB(n=39) | P value | |
Major adverse cardiovascular events | 3 (7.7) | 0.020 |
Cardiac death | 0 | 0.022 |
Myocardial infarction | 1 (2.6) | 0.353 |
Stent thrombosis | 0 | 0.241 |
Target lesion revascularization | 2 (5.1) | 0.164 |
Target vessel revascularization | 2 (5.1) | 0.329 |
Stent Diamiter(mm) | 10 | 15 | 18 | 20 | 25 | 30 | 35 | 40 |
2.25 | GDEB-10-225 | GDEB-15-225 | GDEB-18-225 | GDEB-20-225 | GDEB-25-225 | GDEB-30-225 | GDEB-35-225 | GDEB-40-225 |
2.50 | GDEB-10-250 | GDEB-15-250 | GDEB-18-250 | GDEB-20-250 | GDEB-25-250 | GDEB-30-250 | GDEB-35-250 | GDEB-40-250 |
2.75 | GDEB-10-275 | GDEB-15-275 | GDEB-18-275 | GDEB-20-275 | GDEB-25-275 | GDEB-30-275 | GDEB-35-275 | GDEB-40-275 |
3.00 | GDEB-10-300 | GDEB-15-300 | GDEB-18-300 | GDEB-20-300 | GDEB-25-300 | GDEB-30-300 | GDEB-35-300 | GDEB-40-300 |
3.25 | GDEB-10-325 | GDEB-15-325 | GDEB-18-325 | GDEB-20-325 | GDEB-25-325 | GDEB-30-325 | GDEB-35-325 | GDEB-40-325 |
3.50 | GDEB-10-350 | GDEB-15-350 | GDEB-18-350 | GDEB-20-350 | GDEB-25-350 | GDEB-30-350 | GDEB-35-350 | GDEB-40-350 |
3.75 | GDEB-10-375 | GDEB-15-375 | GDEB-18-375 | GDEB-20-375 | GDEB-25-375 | GDEB-30-375 | GDEB-35-375 | GDEB-40-375 |
4.00 | GDEB-10-400 | GDEB-15-400 | GDEB-18-400 | GDEB-20-400 | GDEB-25-400 | GDEB-30-400 | GDEB-35-400 | GDEB-40-400 |